Skip to main content
Signal8

HLK Biotech Holding Group, Inc. (AMHD)

HLK Biotech Holding Group, Inc. operates primarily through its various subsidiaries, focusing on the production and distribution of biodiesel. In addition to its energy sector activities, the company also engages in the acquisition of real estate assets. The firm was formerly recognized as Amelot Holdings, Inc., but it officially rebranded to HLK Biotech Holding Group, Inc. in February 2018. The company's principal office is located in Norfolk, Virginia.

Sector: Drug Manufacturers - Specialty & Generic

Industry: Drug Manufacturers - Specialty & Generic

HLK Biotech Holding Group, Inc. logo

HLK Biotech Holding Group, Inc.

OTC:AMHDHealthcare
$0.0003
CLOSED
Mkt Cap$1K
EV-
Float-
O/S4.63M
VOL1K sh
$ Vol$0
RVOL1.00×
Inst Own-
Net Cash/Sh-
Dilution
Short interest (FINRA)
Not computed: no float on record for this company.
Not published: no settled short interest on record.
Not stated: no basis-consistent volume to divide the settled position by.
Borrow (IBKR)

The cost to borrow AMHD shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
No fails on record for 16–31 Oct 2026.
Price, short interest & fails to deliver

No price or settlement history available to chart.

Off-exchange short volume

FINRA publishes no off-exchange short volume for this symbol.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for AMHD: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually